Johnson & Johnson
JNJ
256.81
-1.65
-0.64%
Johnson & Johnson
US · JNJ
#25 by market cap
Listed 1970
256.81
-1.65
-0.64%
Live - 5344 symbols - heartbeat 440s ago
· 2026-10-08 15:30
Pre-market
257.48
-0.38%
After-hours
257.80
-0.25%
Overnight
257.75
-0.27%
- Market cap
- 618.87B
- P/E (TTM)i
- 29.79
- P/Bi
- 7.28
- EPSi
- 11.03
- Div yieldi
- 2.04%
- 52W posi
- 76%
Reader sentiment
Are you bullish or bearish on JNJ?
Anonymous reader poll. Unscientific, not investment advice.
About Johnson & Johnson
Johnson & Johnson is a healthcare holding company split into two segments since spinning off its consumer-health business: Innovative Medicine, covering immunology, oncology, neuroscience, cardiovascular and pulmonary disease, and MedTech, which makes devices for surgery, orthopaedics, vision and other interventional care. Robert Wood Johnson, James Wood Johnson and Edward Mead Johnson Sr. founded the company in New Brunswick, New Jersey, in 1887, where it remains based.
- Founded
- 1887
- CEO
- Mr. Joaquin Duato
- Employees
- 138,200
- Headquarters
- New Brunswick, New Jersey, United States of America
- Fiscal year end
- 12-27
- Website
- jnj.com
Company profile
- Exchange
- US
- Symbol
- JNJ
- Market-cap rank
- #25
- Listing date
- 1970-01-01
- Market cap
- 618.87B
- Float cap
- 617.87B
- Shares out
- 2.41B
- Float shares
- 2.41B
Sectors & themes
Drug Manufacturers - General
CAR-T Therapy
Infectious Disease
Government Pension Fund of Norway
Global medical industry
Regular Savings Plan
Fractional Shares JP
Star Stocks
Quote time 2026-10-08 15:30:04 · For reference only, not investment advice and not tailored to your situation.